pharmacies faced with stock shortages of Doliprane capsules

In pharmacies, for several months, boxes of Doliprane 1,000 mg capsules are becoming increasingly rare in France. How to explain this phenomenon ? Should we be worried?

The media are alarmed by stock shortages of Doliprane 1,000mg capsules. Thus, according to La Dépêche du Midi, several pharmacies would be affected by this phenomenon. A finding that is all the more surprising when you know that the 500 gram format does not suffer from any restocking problems. A break that would be directly linked to the health crisis. Decryption.

Read also >> Long Covid: women have more symptoms than men, study finds

How to explain this increase?

In recent months, specialists have been able to observe a resurgence of winter pathologies, in particular the flu, the return of which has particularly affected the over 65s. A first factor in the increase in the consumption of Doliprane, as explained by the president of the Federation of Pharmaceutical Unions of France, interviewed by BFM Business: “there has indeed been a strong demand for paracetamol and Doliprane for two years. And it has increased further with the winter flu epidemic. »

This epidemic can therefore explain the stock-outs, even if the flu is not the only reason for this phenomenon. In fact, it is above all the Covid-19 who played a key role. It should be noted that the incidence rate of Covid-19 is still high, with 58,954 new cases confirmed on April 25, according to Santé Publique France. It is now the Omicron variant which is the majority and causes mild forms…

Read the rest of the article on Elle.fr

Read also

Leave a Replay